Endpoints News 生物医药· Shelby Livingston·· 22 天前AI 评分40
HHS以“安全”和“自由”为由,将允许部分健康用途肽类的配制
Citing 'safety' and 'freedom,' HHS will allow compounding of certain wellness peptides
AI 导读
HHS周三表示,将停止执行对某些热门健康用途肽类配制的禁令,理由涉及“安全”和“自由”。该决定是在FDA继续处理相关事务期间作出的。
正文
HHS on Wednesday said it will stop enforcing a ban on the compounding of certain popular peptides used for wellness purposes while the FDA works …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
来源:Endpoints News 生物医药 · endpoints.news